Levossimendano Kalceks (Levosimendan)

Levosimendan increases the sensitivity of cardiac troponin C to calcium, which enhances contractile force without raising intracellular calcium concentrations. At the same time it opens ATP‑sensitive potassium channels in vascular smooth muscle, producing arterial and venous dilation. This dual action improves cardiac output while reducing preload and afterload.

The dosing regimen for Levossimendano Kalceks is determined by the prescribing clinician based on the patient’s clinical condition, weight, and response. Specific infusion rates, loading doses, and duration are individualized and should follow local guidelines and the product’s prescribing information.

Safety data for levosimendan in pregnancy and lactation are limited. The product should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant. Consultation with a specialist and careful risk‑benefit assessment are recommended before use in these populations.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams across international markets. After the request, the sales team will verify trade or institutional credentials and respond with pricing, availability, shipping details (including cold‑chain if required) and any necessary import documentation.

The primary alternative to levosimendan is dobutamine, a β‑adrenergic inotrope. Dobutamine increases contractility by raising intracellular cyclic AMP, which can elevate heart rate and myocardial oxygen consumption. Levosimendan, by sensitizing troponin C and causing vasodilation, often provides a more balanced hemodynamic profile with less tachycardia and lower risk of ischemia, though individual patient factors dictate choice.

Levossimendano Kalceks should be stored at ambient temperature, preferably below 25 °C. Keep the vial in its original packaging, protect it from direct light and moisture, and avoid freezing. Inspect the solution for particulate matter or discoloration before use, and follow aseptic techniques during preparation and administration.

The product is administered by intravenous infusion under continuous medical supervision. A typical protocol includes a loading infusion followed by a maintenance infusion, with dosage adjusted according to hemodynamic response and tolerability. Monitoring of blood pressure, heart rate, and ECG is essential throughout the infusion period.

Serious adverse events include ventricular arrhythmias, myocardial ischemia, severe hypotension, and hypersensitivity reactions such as anaphylaxis. Patients should be closely monitored for rhythm disturbances, chest pain, and abrupt drops in blood pressure, and immediate medical intervention should be available if any of these events occur.

Levossimendano Kalceks is contraindicated in patients with known hypersensitivity to levosimendan or any excipients, in those with severe hypotension unresponsive to treatment